 |
Acorda Therapeutics (NASDAQ: ACOR) was established
to develop therapies that restore neurological function to people
with spinal cord injury (SCI), multiple sclerosis (MS) and related
conditions of the nervous system.
View site ›› |
 |
 |
|
AcousTx is an early stage medical device company
dedicated to developing image guided therapeutic medical
products to treat significant medical needs.
View
site ›› |
|
 |
|
Arcadia Biosciences is an agricultural biotechnology company focused on the development
of agricultural products that improve the environment and enhance human health.
View site ›› |
|
 |
|
Asthmatx Inc. designs, develops and manufactures
catheter based medical devices incorporating thermal energy
for a variety of indications.
View
site ›› |
|
 |
|
Biolex Therapeutics is developing and commercializing
therapeutic proteins based on its proprietary LEX System, an expression system that enables
the production of hard-to-make proteins and the optimization of monoclonal antibodies.
View site ›› |
|
 |
|
Bioheart Inc. - We are a biotechnology company
focused on the discovery, development and, subject to regulatory
approval, commercialization of autologous cell therapies
for the treatment of chronic and acute heart damage.
View
site ›› |
|
 |
|
Biophan Technologies - Biophan is a technology
development company serving the healthcare industry, focused
on commercializing the Myotech Circulatory Support System
(CSS) - a novel, non-blood-contacting heart pump for patients
with acute heart failure. The Company has also developed
technologies for MRI image compatibility of medical devices,
as well as other technologies being developed through grants
and partnerships.
View
site ›› |
|
 |
|
Biosurface Engineering Tech
View
site ››
|
|
|
|
Broncus Technologies is a medical technology
company focused on developing minimally-invasive medical
devices for emphysema and other lung diseases.
View
site ›› |
|
 |
|
CardioNet is the world's leading supplier of
mobile cardiac outpatient telemetry. CardioNet provides the
next-generation ambulatory cardiac monitoring service with
beat-to-beat, real time analysis, automatic arrhythmia detection
and wireless ECG transmission.
View site ››
|
|
 |
|
Coapt designs, develops, manufactures and markets bio absorbable implants
specifically to provide surgeons with the next generation of soft tissue fixation technology.
View site ›› |
|
 |
|
CoAptus Medical Corporation is an early stage
medical device company developing a therapeutic product for
the treatment of a structural heart defect called a patent
foramen ovale, or PFO.
View
site ›› |
|
 |
|
CoAxiaTM is a development stage, private, venture-backed
medical device company in clinical trials with an innovative,
catheter-based therapy for the treatment of cerebral ischemia,
most notably: ischemic stroke.
View
site ›› |
|
 |
|
Acquired by Allscripts (NASDAQ: MDRX) in 2008
Extended Care Information Network's (ECIN)
business to business products and services use Internet-based connectivity
to fully automate and enhance the discharge planning process for hospitals
and health systems.
View site ›› |
|
 |
|
Investment managed but not owned:
Emageon (NASDAQ: EMAG) provides a suite of products and services that
allows physicians and healthcare professionals to manage, access,
and visualize multi-specialty medical content across the enterprise
using advanced visualization tools and specialized workflow through
a dynamic user interface.
View site ›› |
|
 |
|
E-Pill Pharma was founded in 2003 to provide
an effective new platform for oral delivery of drugs that
are currently administered parenterally (by injection or
intravenously).
View
site ›› |
|
 |
 |
ESTECH is a privately held medical device manufacturing
and distribution company located in San Ramon, California.
The company was founded by Arthur and Raymond Bertolero in 1996 with
an emphasis on least invasive products for cardiac surgery. ESTECH has
grown to over 45 employees with worldwide distribution and
has consistently attracted goal oriented professionals who represent
the brightest minds in the medical device industry. The in-depth professional
experience and tireless dedication of the ESTECH Team has allowed the
company to achieve rapid and sustained success in this highly competitive
environment. ESTECH is proud of each employee from every department and
thanks them for their contribution and support.
View
site ›› |
|
 |
|
Evalve was incorporated in 1999 to design,
develop, manufacture and market innovative devices to enable
percutaneous repair of cardiac valves.
View
site ››
|
|
 |
|
Genesis Medical Interventional, Inc. is a funnel
catheter company committed to advancing cardiovascular healthcare
by designing safe, easy-to-use products to treat occlusive
vascular diseases.
View
site ››
|
|
 |
|
| GMP Companies was originally founded as a healthcare company
seeking to acquire, develop and commercialize novel medical technologies. Today, LifeSync Corporation
is the sole business of GMP Companies. LifeSync produces wireless patient monitoring leads and
transceivers to create a Personal Area Network between patient and monitor.
View site ›› |
|
 |
|
| GRAFTcath
develops femoral vascular closure following interventional
procedures. The company also develops vascular access
products for hemodialysis.
It offers a device that seals blood
vessels after hemodialysis and other procedures
for patients with end-stage
renal disease. |
|
 |
|
Illumina develops tools for the large-scale analysis of genetic variation
and function.
View site ›› |
|
 |
|
ImaRx Therapeutics, Inc.
We are a biopharmaceutical company developing and commercializing
therapies for vascular disorders.
View
site ›› |
|
 |
|
InnFocus is a biomaterials-based company established
to develop novel products in ophthalmology that are not readily
achievable with traditional biomaterials.
View
site ›› |
|
 |
|
InnoGraft LLC was spun off from Innovia in
2003 to develop novel sealants for conventional large caliber
vascular grafts and to leverage this technology to enable
small caliber vascular grafts.
View
site ›› |
|
 |
|
LifeMasters provides technology-enabled chronic-disease management
services to individuals, physicians and payors.
View site ›› |
|
 |
|
Laureate Pharma provides superior bioprocessing services
that accelerate new products from development through production.
View
site ›› |
|
 |
|
Locus Pharmaceuticals is a privately held pharmaceutical company focused on developing novel, small molecule therapeutic drugs to address major unmet medical needs.
View site ›› |
|
 |
|
Lombard Medical Technologies (LMT) develops,
manufactures and markets stent grafts for the treatment of
abdominal and thoracic aortic aneurysms, endovascular stapling
devices for the fixation of stent grafts and percutaneous
heart valves, and develops drug delivery coatings.
View
site ›› |
|
 |
|
Acquired by WebMD (NASDAQ: WBMD) in 2006
eMedicine provides the largest and most
current Clinical Knowledge Base available to physicians and health
professionals.
View site ›› |
|
 |
|
Medivas has pioneered a unique drug and biologic
delivery system through the use of a new family of biodegradable
polymers.
View
site ›› |
|
 |
|
|
Acquired by WebMD (NASDAQ: WBMD) in 2006
Medsite uses the power of the Internet to provide a full suite
of online marketing and educational services that broaden reach,
cement relationships, and deliver rewards to physicians.
View
site ›› |
|
 |
|
MedVantx created the first Generic
Delivery Network that benefits payors,
physicians and patients by providing
first-line generic medication therapy
free to patients at the point of care.
View site ›› |
|
 |
|
Natural Pharmaceuticals, Inc. (NPI), founded
in 1998, produces a sustainable supply of semi-synthetic
paclitaxel API for clinical research and commercial sales
at competitive prices for the gobal market. NPI additionally
produces docetaxel.
View
site ›› |
|
 |
|
Neuronyx is a pioneer in the use of adult bone marrow-derived
somatic cells (hABM-SC) and we believe the first company to
test the ability of directly delivered cells to repair damaged cardiac
tissue in patients who have suffered a heart attack.
View
site ›› |
|
 |
|
Notal Vision is developing the first comprehensive diagnostic solutions for the early detection and frequent monitoring of Age-Related Macular Degeneration, the leading cause of blindness in the western world today.
View site ›› |
|
 |
|
OccuLogix, Inc. is a health care company focused
on evidence-based ophthalmic devices for the diagnosis and
treatment of age related eye diseases.
View
site ›› |
|
 |
|
Orqis Medical’s mission is to redefine
heart failure therapy by developing devices that prevent
or reverse the underlying disease progression of heart failure.
View
site ›› |
|
 |
|
PatientKeeper provides healthcare professionals with mobile computing solutions that help improve patient care and curb rising costs.
View site ›› |
|
 |
|
POINT Biomedical was founded to pursue technologies related to
imaging and drug delivery. POINT's core technology is based upon an ultrasonically responsive
two-layer, biodegradable microsphere or biSphere.
View site ›› |
|
 |
|
Acquired by Wolters Kluwer in 2006
ProVation provides a multi-disciplinary documentation solution with a growing array of specialty medical-content cartridges that run on a single, powerful platform.
View site ›› |
|
 |
|
|
Acquired by Hologic (NASDAQ: HOLX) in 2006
R2 Technology, Inc. is the recognized leader in the development
and commercialization of computer aided detection (CAD), an innovative
technology that assists physicians in the earlier detection of breast
cancer, actionable lung nodules and other lung abnormalities.
View
site ›› |
|
 |
|
Raven Biotechnologies is focused on the development of
monoclonal antibody therapeutics for treating cancer.
View site ›› |
|
 |
|
REVA Medical is dedicated
to developing interventional medical devices that leverage
the Company's novel stent designs and biomaterials to improve
the treatment of vascular disease.
View
site ›› |
|
 |
|
Solace Therapeutics is an emerging medical
device company focused on the development of non-surgical
office based treatments for common bladder disorders, such
as stress urinary incontinence (SUI), overactive bladder
(OAB), male voiding dysfunction and lower urinary tract symptoms
(LUTS).
View
site ›› |
|
 |
|
Spiration is committed to improving quality
of life for patients with acute and chronic conditions of
the lung through the development of novel therapies. Founded
in 1999 in Redmond, Wash., Spiration is a pioneer in its
field, with more than 55 issued or pending patents addressing
various conditions of the lung.
View
site ›› |
|
 |
|
A leading, privately-held biomedical company,
TEI Biosciences has applied its expertise in regenerative
medicine to develop and commercialize novel biologic products
for a broad spectrum of soft tissue repair and reinforcement
applications - from dura, tendon, and hernia repair to wound
management and plastic and reconstructive surgery.
View
site ›› |
|
 |
|
Theregen, Inc. is a regenerative medicine company
that is developing cell-based therapies for cardiovascular
indications. Anginera™, Theregen's lead product, is
an epicardial patch designed to improve cardiac function
in patients.
View
site ›› |
|
 |
|
Therus Corporation is developing the Therus® Acoustic
Hemostasis System, a medical device designed for rapid, durable,
noninvasive sealing of femoral artery access punctures following
catheterization-laboratory procedures such as angiography
and angioplasty.
View site ›› |
|
 |
|
VIA Pharmaceuticals is a biotechnology company
focused on the treatment of cardiovascular disease.
View
site ›› |
|
 |
|
VisionCare Ophthalmic Technologies (VisionCare)
is a privately-held development stage company engaged in
the research, development, manufacture, and marketing of
proprietary implantable ophthalmic devices and technologies
that are intended to significantly improve vision and quality
of life for individuals with untreatable retinal disorders.
View
site ›› |
|
 |
|
Zonare designs, develops, and manufactures high performance portable ultrasound products, which combine revolutionary technology with an innovative physical design to achieve unsurpassed customer value in the global ultrasound market.
View site ›› |
|
 |
